Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
31 results about "Massive bleeding" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Calcium-complex starch-based microporous haemostatic material, and preparation method and application thereof
ActiveCN102526794ARapid hemostasisQuick and powerful hemostasisAbsorbent padsBandagesHaemostatic functionBiocompatibility Testing
The invention relates to a calcium-complex starch-based microporous haemostatic material, and a preparation method and application thereof. The preparation method comprises the following steps of: firstly, preparing microporous starch loaded with carboxymethyl; secondly, complexing and assembling calcium ions; and finally, preparing the calcium-complex starch-based microporous haemostatic material, which has the pore diameter of 0.1-5um, the haemostatic time of 20 seconds to 30 minutes and can be completely degraded within 8 hours to 6 days. The cost of raw materials is low; the preparation method is simple; the obtained haemostatic material combines the physical haemostatic function of the microporous starch and the chemical haemostatic function of the carboxymethyl and the calcium ions, so that the haemostatic material is quick in haemostasis, high in efficiency, large in viscosity and good in biocompatibility, can be degraded in a body, and can be used for stopping bleeding of bleeding places such as human epidermis and internal tissues, massive bleeding places or active places of substantial organs in the body, and places where bleeding is difficult to control.
Owner:苏州佰济生物科技有限公司
Rapid bleeding-stopping dressing for department of gynaecology and obstetrics and preparation method of rapid bleeding-stopping dressing
InactiveCN105288706AImprove cohesionRapid hemostasisAbsorbent padsBandagesExcessive BleedingEmergency treatment
The invention belongs to the field of medical materials for the department of gynaecology and obstetrics, in particular relates to rapid bleeding-stopping dressing for the department of gynaecology and obstetrics, and further discloses a preparation method of the rapid bleeding-stopping dressing. The rapid bleeding-stopping dressing is prepared by taking carboxymethyl chitosan, sodium carboxymethylcellulose, collagen, radix notoginseng and polyving akohol as raw materials, and the form of firstly foaming and then carrying out freeze drying in the gradient form is adopted in the preparation process; compared with the product obtained by the conventional single freeze drying form in the prior art, the prepared bleeding-stopping dressing has the advantages that on the aspects of absorption and bleeding stopping effects, the technical effect of absorbing blood is greatly promoted; the rapid bleeding-stopping dressing has the optimal bleeding stopping effect for the rapid haemorrhagic disease, can realize stopping bleeding within short time, and can be applicable to the emergency treatment for the acute excessive bleeding of the department of gynaecology and obstetrics.
Owner:李星华
Chitosan fiber-based efficient hemostatic material and preparation method thereof
ActiveCN112972749ALarge specific surface areaHigh strengthSurgical adhesivesPharmaceutical delivery mechanismPolymer scienceRed blood cell
The invention provides a chitosan fiber-based efficient hemostatic material and a preparation method thereof. The preparation method comprises the following steps of spinning chitosan to obtain a chitosan fiber base material, and grafting carboxyl and catechol structures on the chitosan fiber base material at the same time. The hemostatic material can quickly absorb moisture in blood to swell, so that the hemostatic rate is remarkably improved. The carboxyl is introduced, so that the hemostatic material has super-strong imbibition capacity, platelets in blood of a bleeding part are quickly adhered and aggregated to form thrombus, hydroxyl on the catechol group can be complexed with iron ions in red blood cells, the red blood cells are aggregated to play a role in stabilizing blood clots, and finally, the effect of quickly stopping bleeding is achieved. The efficient hemostatic material provided by the invention is especially suitable for the condition of massive bleeding.
Owner:WUHAN TEXTILE UNIV
Pillbug extract and application thereof
ActiveCN104523758AThrombolyticCtiveAnthropod material medical ingredientsBlood disorderMedicineActivator plasminogen
The invention provides a pillbug extract and an application thereof, relating to the field of pharmaceuticals. The pillbug extract has thrombolytic and anti-coagulant activities, and is prepared by adopting a method including the following steps: performing wet-process superfine grinding on pillbug, centrifuging, and collecting supernatant liquid to obtain the pillbug extract. The pillbug extract has thrombolytic and anti-coagulant activities, and is relatively mild in thrombolytic activity. According to the pillbug extract provided by the invention, a mode that fibrin is directly dissolved is not adopted, but a mode that plasminogen is activated to ensure that plasminogen is transformed into plasmin and thus fibrin is dissolved is adopted, so that the pillbug extract has relatively mild thrombolytic effects, the tendency of massive bleeding cannot be caused, and the risk of massive hemorrhage of tissues can be reduced. In addition, the pillbug extract provided by the invention is feasible and effective in preparation method, simple and convenient in technological process and easy to operate, and is suitable for industrial production. The pillbug extract provided by the invention can also be applied to the preparation of medicines for treating thrombotic diseases.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Gingival bleeding stopping device used after tooth extraction of children for pediatric dentistry
InactiveCN107432772ASimple structureSimple and fast operationMedical devicesDental toolsStops deviceEngineering
The invention discloses a paediatric oral cavity hemostasis device for children's gums after tooth extraction, comprising an L-shaped clamping plate, two sliding grooves are arranged on one side of the lower surface of the horizontal plate of the L-shaped clamping plate, and sliding grooves are provided in the sliding grooves The connected sliding card plate, the horizontal plate side of the L-shaped card plate is provided with an ear plate, and two first electric telescopic rods are arranged between one side of the ear plate and the sliding card plate. The cardboard can fix both sides of the gums after tooth extraction, so as to prevent the gums from bleeding a lot. The hemostatic potion in the liquid tank can be pumped to the water spray head through the micro water pump, and the potion can be sprayed on the wound of the gums through the water spray head to stop the bleeding. , so that the hemostasis effect is better. The pediatric oral cavity is used for the gingival hemostasis device for children after tooth extraction. The structure is simple and the operation is simple.
Owner:吴洪华
Pharmaceutical composition containing dabigatran etexilate and preparation method thereof
ActiveCN110339193ARandom combinationStable concentrationOrganic active ingredientsPowder deliverySide effectAdditive ingredient
The invention discloses a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises active pharmaceutical ingredients and anamphoteric polymer; wherein the pharmaceutical active ingredients are dabigatran etexilate and / or dabigatran etexilate mesylate (DEM), and the amphoteric polymer is a graft copolymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol; and a mass ratio of the active pharmaceutical ingredients to the amphoteric polymer is 1: 0.23-1: 3. The pharmaceutical composition can not only improvethe bioavailability of the active pharmaceutical ingredients, but also reduce the absorption variability, and simultaneously provide a more stable concentration of dabigatran in blood plasma, therebyreducing adverse side effects and reducing the possibility of gastrointestinal tract (GIT) bleeding. In addition, due to the enhanced absorption, there is a significant reduction in non-absorbed DEMin gastrointestinal tracts, which can further alleviate the GIT massive bleeding.
Owner:SHANGHAI WD PHARM CO LTD
Rapid hemostatic dressing for obstetrics and gynecology and preparation method thereof
InactiveCN108498844AQuick condensationFreeze fastPharmaceutical delivery mechanismAbsorbent padsObstetric historyRed blood cell
The invention discloses a rapid hemostatic dressing for obstetrics and gynecology and a preparation method thereof. The rapid hemostatic dressing comprises the following raw materials: human-like collagen, hyaluronic acid, a plasticizer, thrombin, chitosan, heparin sodium, aloin, hydroxymethyl chitin, alginate, an antibacterial agent, an anti-inflammatory agent, starch, sodium carboxymethyl cellulose, polyvinyl alcohol, notoginseng, dextrin and gelatin, the preparation method comprises the following steps: preparation of the raw materials, preparation of an ointment, mixing and foaming; the preparation method is simple, scientific and reasonable, can quickly stop bleeding and inhibit bacteria, and the effect is obvious, the film-like dressing is suitable for rapid hemostasis, antisepsis and anti-inflammationand promoting of wound healing in obstetrics and gynecology, and promotes the function of coagulation of red blood cells; the added collagen can not only play a coagulation effect,but also promote wound healing, can achieve hemostasis in a short time, can be applied to the emergency treatment of acute massive bleeding in obstetrics and gynecology, and has no toxicity and smallside effects to the human body.
Owner:张祖玲
Starch stypticum and preparation method thereof
ActiveCN102178691BImprove migration abilityRapid hemostasisOrganic active ingredientsSurgical drugsGynecology departmentAbsorption rate
The invention discloses a starch stypticum and a preparation method thereof, belonging to the field of medical preparations. The preparation method comprises the following steps: refining waxy maize starch to 4,000 to 10,000 meshes; centrifugally filtering after crosslinking, acidolysis and enzymolysis are completed; cleaning with distilled water; blasting and drying at constant temperature untilthe weight is constant; crushing, and screening through a 200-mesh screen; radiating by Co60 to disinfect to prepare the starch stypticum. The water absorption rate of the starch stypticum prepared by adopting the method is 2 to 3 times that of the conventional styptic materials, the starch stypticum can quickly stop bleeding in actual application, has quick styptic function in great vessel hemorrhage, even massive bleeding wound surface, and can be widely applied to surgeries of cardiothoracic and vascular surgery department, hepatobiliary surgery department, orthopedics department, general surgery department, obstetrics and gynecology department, urology surgery department and ear-nose-throat department and the like.
Owner:北京爱特康医疗科技有限公司
Bleeding point detection system
InactiveCN111419202AAvoid profuse bleedingAvoid blood lossAntifouling/underwater paintsSurgical needlesControl cellMassive blood loss
The invention relates to the technical field of medical instruments, in particular to a bleeding point detection system. The system comprises a bleeding point detection unit, a control unit, an alarmunit and a power supply unit, the control unit is electrically connected to the bleeding point detection unit, the alarm unit and the power supply unit are both electrically connected to the control unit, and the alarm unit is electrically connected to the power supply unit; and the bleeding point detection unit is used for monitoring the bleeding condition of a puncture position of a patient in real time and generating an electric signal to be uploaded to the control unit when the bleeding of a puncture position is monitored. The system can realize the purpose of monitoring the bleeding condition of the puncture position of the patient in real time, and can timely send an alarm sound to inform medical personnel to timely process the bleeding condition of the puncture position of the patient when the bleeding condition of the puncture position of the patient is monitored, thereby avoiding massive bleeding of the puncture position of the patient, further avoiding massive bleeding of thepatient. The system is firm in wearing, convenient to use, good in practicability and good in antibacterial performance.
Owner:THE FIRST PEOPLES HOSPITAL OF CHANGZHOU
Interventional control system and control method for preventing massive bleeding in department of cardiology
InactiveCN111449750AImplement automatic placementEasy to interveneStentsImage enhancementImaging processingImaging analysis
The invention belongs to the technical field of image processing, and discloses an interventional control system and control method for preventing massive bleeding in a department of cardiology. The interventional control system for preventing massive bleeding in the department of cardiology is provided with an image acquisition module, an image analysis module, a central control module, a positioning module, a path determining module, a hydraulic monitoring module, an intervention stent, an intervention stent placing module, a pressurizing module, a pressure detection module, a stent releasedetection module, an alarm module and a display module; and the interventional control method for preventing massive bleeding in the department of cardiology comprises the steps of acquiring and analyzing a heart contrast image; determining a movement path of the intervention stent; placing the intervention stent; and pressurizing a balloon and performing pressure detection. The positioning moduleand the path determining module are arranged to facilitate intervention by a doctor; and the pressurizing module and the pressure detection module cooperate to control pressurization of the balloon in the intervention stent, effectively protect blood vessels and reduce the operation risk.
Owner:刘强
Cardiology department intervention device for preventing excessive bleeding
InactiveCN104546030ARelieve painAvoid wasting timeSurgical needlesTrocarExcessive BleedingInfection risks
The invention discloses a cardiology department intervention device for preventing excessive bleeding. The cardiology department intervention device comprises a syringe needle, a needle cylinder and a push-and-pull rod; the needle cylinder is composed of an inner cylinder and an outer cylinder; the syringe needle is connected to the outer cylinder of the needle cylinder; the inner cylinder is provided with the push-and-pull rod with a piston; a guide wire pipe is arranged on the push-and-pull rod and penetrates the piston; an elastic sealing cover is arranged at the position, on the surface of the piston, of the guide wire pipe; a guide wire is fixed to the elastic sealing cover; in the manufacturing process, the guide wire is placed on the guide wire pipe to be fixed to the elastic sealing cover; time waste caused by the fact that the elastic sealing cover is punctured through the guide wire in the operation process is avoided; pains of patients are reduced; and the operation time is shortened. Meanwhile, the infection risks caused by manual operation are avoided. The cardiology department intervention device is simple in structure, convenient to use, safe in use and suitable for wide popularization.
Owner:HARBIN GUANGKAI TECH DEV
Gynecological rapid hemostatic dressing and preparation method thereof
InactiveCN111603603AGood curative effectLittle side effectsPharmaceutical delivery mechanismAbsorbent padsGynecology departmentBlood coagulations
The invention discloses a gynecological rapid hemostatic dressing and a preparation method thereof, and belongs to the technical field of medical materials. Compared with the prior art, the inventionprovides a gynecological rapid hemostatic dressing and a preparation method thereof. The operation method is simple, scientific and reasonable, rapid hemostasis and bacteriostasis can be realized; theeffect is obvious; bletilla striata and pseudo-ginseng have the effects of promoting blood circulation and removing blood stasis and have a good curative effect on traumatic bleeding; added collagen,carboxymethyl chitosan, sodium carboxymethyl cellulose, thrombin, heparin sodium and sodium alginate have a wide application range in the prior art; the curative effect of the medicine is improved after preparation; meanwhile, an anti-inflammatory agent is used for assisting the sterilization treatment, the hemostatic effect is further improved; and the hemostatic dressing is free of toxicity inclinical use, small in side effect on a human body, capable of achieving a blood coagulation effect, promoting wound healing and achieving hemostasis within a short time and suitable for emergency treatment of acute massive bleeding in an obstetrics and gynecology department.
Owner:韩皓
Intervention stent capable of preventing massive bleeding, for department of cardiology
The invention relates to an intervention stent capable of preventing massive bleeding, for the department of cardiology. The intervention stent comprises bearing pipe bodies, graphene far end diversion openings and graphene near end diversion openings, wherein each bearing pipe body adopts a net-shaped pipe structure of which the axial section is rectangular; each graphene far end diversion opening and each graphene near end diversion opening both adopt the net-shaped pipe structure of which the axial section is an isosceles trapezoid; and the inflow end of each bearing pipe body communicateswith the corresponding graphene far end diversion opening, and the outflow end of each bearing pipe body communicates with the corresponding graphene near end diversion opening. According to the intervention stent disclosed by the invention, on one side, the intervention stent is low in surface area, good in supporting capacity, good in bearing capacity, good in covering power and good in hydrodynamic performance, so that the blood circulation performance in blood vessels can be effectively improved, and the risk of thrombosis can be effectively reduced; and on the other side, the interventionstent is good in tracing performance, small in end head, impermeable to X-ray, good in biocompatibility and good in blood vessel distensibility, so that convenience and precision of detecting and positioning of the stent after a bypass surgery are greatly improved.
Owner:崇左市人民医院
Medical degradable hemostatic material and preparation method thereof
ActiveCN110538344AMassive absorptionRapid hemostasisSurgical adhesivesPharmaceutical delivery mechanismMicrosphereAntibacterial activity
The invention provides a novel medical degradable hemostatic material and a preparation method thereof. According to the preparation method, a dry-heat crosslinking method is adopted to crosslink chitosan and a derivative thereof, and starch and a derivative thereof, a crosslinked sample is made into a microsphere by a method of electrostatic droplet, in the process of preparing the microsphere, asoluble calcium salt solution is used as stationary liquid, calcium ions are complexed on the microsphere, then physical pore-forming is conducted on the microsphere through a method of ultrasound, aporous microsphere sample is dried through supercritical and sprayed mode, the polysaccharide composite hemostatic material prepared by adopting the preparation method has the advantages of both thestarch and the chitosan, the hemostatic ability is high, antibacterial activity is achieved, toxicity and stimulation are avoided, the process is simple, reagent residue is avoided, pollution is avoided, the cost is low, using is convenient, the polysaccharide composite hemostatic material is suitable for fast hemostasis of massive bleeding, irregular parts and viscera, and also can be used as a raw material of anti-adhesion products, hemostasis products and dressing products.
Owner:NKD PHARMA CO LTD
High-efficiency hemostatic material based on chitosan fiber and its preparation method
ActiveCN112972749BLarge specific surface areaHigh strengthSurgical adhesivesPharmaceutical delivery mechanismFiberCarboxyl radical
Owner:WUHAN TEXTILE UNIV
Robot for removing cancer cells
PendingCN109431607AEasy to operateAchieve the purpose of non-renewableSurgical robotsAbnormal tissue growthCancer cell
The invention discloses a robot for removing cancer cells, which comprises a main engine and an operating table; the middle of the front face of an operation main engine is fixed with an operating table; above the front face of the main engine is fixed with a display device; above one side of the main engine is fixed with a robotic arm; a support is fixed on one side of the robotic arm away from the main engine; a needle is fixed on one side of the support far from the robotic arm; a cavity body is formed in the inner part of the support; an electric motor is fixed above the middle side of theinner part of the cavity body. According to the robot for removing cancer cells, the tumor is treated in the early stage, thereby placing a dissecting device near the cancer cells inside the blood vessel by interventional means, avoiding the risk of massive bleeding caused by aortic vascular incision, and greatly reducing the risk of surgery; at the same time, through a 3D vision device, it is convenient for medical personnel to determine the location of the cancer cells; through an ion thinner, the cancer cells are stripped into the internal vacuum ion thinner, so that cancer cells die naturally.
Owner:SHENYANG HENGTIAN ROBOT MFG CO LTD
An interventional stent for preventing massive bleeding in the Department of Cardiology
ActiveCN110559109BStrong expandabilityPromote blood circulationStentsSurgeryThrombusBiocompatibility
The invention relates to an interventional stent for preventing massive bleeding in the Department of Cardiology, which includes a bearing tube body, a graphene distal diversion port, and a graphene proximal diversion port. The carrier tube body is a mesh tube structure with a rectangular axial section. The graphene distal diversion port and the graphene proximal diversion port are both mesh tube structures with an isosceles trapezoidal axial section. The proximal port is connected. On the one hand, the present invention has small surface area, good supporting force, bearing capacity, covering capacity and hydrodynamic performance, can effectively improve the blood circulation performance in blood vessels, and can effectively reduce the risk of thrombus formation; on the other hand, it has good traceability and small end , X-ray opaque, biocompatibility, and good vasodilation performance, thus greatly improving the convenience and accuracy of stent detection and positioning after heart bypass surgery.
Owner:崇左市人民医院
Interventional stent for preventing massive bleeding in cardiology department
The invention provides an interventional stent for preventing massive bleeding in the cardiology department, and relates to the field of medical instruments. The interventional stent for preventing massive bleeding in the cardiology department comprises a front end opening, wherein metal fibers are arranged in the front end opening, a stent main body is fixedly connected to the right side of the front end opening, fixing convex rings are arranged on the side surface of the stent main body, a slow release layer is arranged on the side surface of the stent main body and located outside the fixing convex rings, and reinforcing ribs are arranged in the stent main body. Through the arrangement of the front end opening and a rear end opening, the stent is convenient to connect, the operation time is shortened, the bleeding amount of a patient is reduced, through the arrangement of a carrying ring, blood circulation in the stent is smoother, blood coagulation is prevented, through the use ofgraphene as a main body material and the arrangement of the slow release layer, foreign body sensation caused by the stent in the human body can be reduced, the human body can comfortable, and besides, the reinforcing ribs and the metal fibers are arranged, so that the stent is stable in structure.
Owner:卢飞飞
Preparation method for fuming therapy haemorrhoids drug
InactiveCN109498766ANew formulaLow costHydroxy compound active ingredientsInanimate material medical ingredientsRegimenPharmaceutical drug
The invention discloses a preparation method for a fuming therapy haemorrhoids drug. The drug is prepared from the following raw materials by weight: 3-8 g of radix sophorae flavescentis, 5-8 g of herba taraxaci, 2-5 g of pericarpium granati, 7-10 g of flos lonicerae, 3-6 g of talcum, 2-5 g of raw radixet rhizoma rhei, 5-8 g of cortex phellodendri, 2-8 g of amber, 5-10 g of radix stemonae, 4-8 g of raw radix sanguisorbae, and 1-2 g of borneol. The preparation method comprises the following steps of: drying the raw materials, and then uniformly mixing to obtain a raw material mixture; smashingthe raw material mixture, then sieving by a 80-mesh sieve, and filtering to remove a drug residue to obtain drug powder; and packaging the drug powder into a small bag every 3 g. The drug powder packaged every 3 g, moxa bagged every 20 g and two scorpios are used together. The drug is capable of treating haemorrhoids by using pure traditional Chinese medicines without performing an operation, andis painless, and suitable for internal haemorrhoids and external haemorrhoids, and a situation of massive bleeding of the internal haemorrhoids can be solved through three courses of treatment. The drug has the advantages of novel formula, low cost, simple and convenient preparation, remarkable effect, and less relapse possibility.
Owner:柳周库
Pharmaceutical composition containing dabigatran etexilate and preparation method thereof
PendingCN110354123ARandom combinationStable concentrationOrganic active ingredientsPharmaceutical non-active ingredientsSide effectPolyethylene glycol
The invention discloses a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutical active component and anamphoteric polymer, wherein the pharmaceutical active component is dabigatran etexilate and / or dabigatran etexilate mesylate; the amphoteric polymer is a polyethylene caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer; the pharmaceutical composition is prepared by hot melt granulation. The pharmaceutical composition not only can improve the bioavailability of the pharmaceutical active component, but also can reduce the absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby alleviating the adverse side effects and reducing the possibility of GIT bleeding. In addition, due to absorption enhancement, unabsorbed DEM in gastrointestinal tracts is significantly reduced, and thus the massive bleeding of GIT can be further alleviated.
Owner:SHANGHAI WD PHARM CO LTD
Vascular punch
ActiveUS11419627B2Easy to provideFacilitate the punch action is not excessiveExcision instrumentsSurgical forcepsBlood vessel operationsVascular surgery
Owner:3R LIFE SCI CORP
Pharmaceutical composition containing dabigatran etexilate and preparation method thereof
PendingCN110354122ARandom combinationStable concentrationOrganic active ingredientsPharmaceutical non-active ingredientsSide effectPolyethylene glycol
The invention discloses a pharmaceutical composition containing dabigatran etexilate. The pharmaceutical composition comprises a pharmaceutical active component, an amphoteric polymer and a hydrophilic polymer, wherein the pharmaceutical active component is dabigatran etexilate and / or dabigatran etexilate mesylate; the amphoteric polymer is a polyethylene caprolactam-polyvinyl acetate-polyethyleneglycol graft copolymer; the hydrophilic polymer is a polyoxyethylene polyoxypropylene ether block copolymer. The pharmaceutical composition not only can improve the bioavailability of the pharmaceutical active component, but also can reduce the absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby alleviating the adverse side effects and reducing the possibility of GIT bleeding. In addition, due to absorption enhancement, unabsorbed DEM in gastrointestinal tracts is significantly reduced, and thus the massive bleeding of GIT can be further alleviated.
Owner:SHANGHAI WD PHARM CO LTD
Emergency treatment device for secondary massive hemorrhage after anus operation and operation method
InactiveCN100496420CEasy to operateThe curative effect is accurate and reliableOrganic active ingredientsEnemata/irrigatorsGynecologyTherapeutic effect
The present invention discloses an emergency treatment device and operation method for secondary massive hemorrhage after anal surgery. The treatment device comprises a balloon catheter with three chambers (1), a drainage vessel (10), a traction rope (13), which is connected with a water injection expansion diverticulum tube (14) of a balloon catheter with three chambers. A washing drainage tube with three chambers (6) is arranged in the outlet of the drainage tube of the balloon catheter with three chambers (3). Compared with current technology, the present invention possesses advantages of convenient operation, convenient observation, and reliable treatment effect. The operation, oberservation and the treatment can be conducted by one person. Situation of the patient can be changed into safety in a short period with proper measures and timely treatment. When the present invention is used in early stage of hemorrhage, life hazard caused by massive hemorrhage can be reduced or eliminated; also infection of blood transmitted disease in patient caused by blood transfusion is reduced or eliminated.
Owner:刘祥和
Vascular punch
ActiveUS20210007768A1Easy to provideFacilitate the punch action is not excessiveExcision instrumentsSurgical forcepsBlood vessel operationsVascular surgery
The invention discloses a novel vascular punch employing compressive normal force for tissue separation from a targeted vessel. This invention is particularly designed for making a large round hole without massive bleeding in vascular surgery. A clean, non-frayed hole-making guided by the normal force cutting principle is realized using a site-biting punch mechanism. The side-biting vascular punch comprises a U-shaped razor blade cutter, a backstop for receiving the cutter, and a linkage mechanism, forming an aligned line of contact for normal compression force generation and thereby severing tissue out of the targeted vessel.
Owner:3R LIFE SCI CORP
A kind of ratwort extract and its application
ActiveCN104523758BMild thrombolysisThe preparation method worksAnthropod material medical ingredientsBlood disorderMedicineRat skin extract
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Calcium-complex starch-based microporous haemostatic material, and preparation method and application thereof
ActiveCN102526794BHas antibacterial propertiesRapid hemostasisAbsorbent padsBandagesHaemostatic functionCuticle
The invention relates to a calcium-complex starch-based microporous haemostatic material, and a preparation method and application thereof. The preparation method comprises the following steps of: firstly, preparing microporous starch loaded with carboxymethyl; secondly, complexing and assembling calcium ions; and finally, preparing the calcium-complex starch-based microporous haemostatic material, which has the pore diameter of 0.1-5um, the haemostatic time of 20 seconds to 30 minutes and can be completely degraded within 8 hours to 6 days. The cost of raw materials is low; the preparation method is simple; the obtained haemostatic material combines the physical haemostatic function of the microporous starch and the chemical haemostatic function of the carboxymethyl and the calcium ions, so that the haemostatic material is quick in haemostasis, high in efficiency, large in viscosity and good in biocompatibility, can be degraded in a body, and can be used for stopping bleeding of bleeding places such as human epidermis and internal tissues, massive bleeding places or active places of substantial organs in the body, and places where bleeding is difficult to control.
Owner:苏州佰济生物科技有限公司
Probe structure for gynecological therapeutic apparatus
InactiveCN102688562ASpeed efficientAvoid profuse bleedingUltrasound therapyBathing devicesOral medicineOzone generator
The invention discloses a probe structure for a gynecological therapeutic apparatus. The probe structure comprises an ozone therapeutic probe and an ultrasonic therapeutic probe which are respectively connected to a controller. The ozone therapeutic probe is connected to an ozone generator through a flexible aerial fog guide tube. The ultrasonic therapeutic probe comprises a work end, an operating handle and a data line, and the data line is connected with the controller through a joint. The probe structure for the gynecological therapeutic apparatus is capable of permeating deeply and sterilizing instantly, the onset time of the probe structure is much shorter than those of a conventional oral medicines and external-use suppository, while defects that operations are complicated, patients are easy to suffer massive bleeding and drainage, feel pain and the like when in common microwave therapy and laser therapy processes are overcome, and accordingly a safety guarantee is provided for hospital and patients.
Owner:林明钜
Parturient recovery pillow
The invention discloses a parturient recovery pillow. The parturient recovery pillow comprises a pillow outer case and a pillow interior case. Pillow interior materials are arranged in the pillow interior case. The parturient recovery pillow is characterized in that the pillow interior materials comprise acorus gramineus, wild chrysanthemum, fructus cnidii, radix sophorae flavescentis and alpha-asarone and leonurine bagged materials. The parturient recovery pillow has the advantages that the parturient recovery pillow is strongly targeted and has certain functions of promoting blood circulation to remove blood stasis, regulating menstruation, eliminating edema, resolving dampness, promoting appetite, restoring consciousness, promoting intelligence, dredging the channels, resisting bacteria and inflammation for treating leukorrhea with reddish discharge, clearing away heat, drying dampness and tonifying yin qi for a woman, has the good auxiliary physical therapy function on treating parturient massive bleeding, the vital-energy-deficiency syndrome, abdominal pain due to blood stasis and incomplete uterine contraction, and has the good health care function on parturient health recovery.
Owner:吴清
Head supporting and positioning device for neurosurgery department and positioning method thereof
InactiveCN114343958AReduce bleedingDecreased blood flowDiagnosticsOperating tablesMajor bleedingAlcohol
The invention discloses a neurosurgery head supporting and positioning device and a positioning method thereof, and belongs to the technical field of medical instruments. A head supporting and positioning device for the neurosurgery department comprises a mounting base and an alcohol box, and the alcohol box is arranged at the bottom of the mounting base; the hollow pillow made of heat conduction metal is attached to the neck of a patient, and alcohol circularly flows in the hollow pillow and the alcohol box, so that the blood flow rate of the neck is reduced, the flow rate of blood entering the brain from the neck is reduced, the bleeding amount of the patient in the treatment process is reduced, and the treatment success rate is increased; alcohol is smeared on the head of a patient, the head of the patient is disinfected, meanwhile, heat of the head of the patient is absorbed through the alcohol, the head of the patient is cooled, the blood flowing speed of the head of the patient is reduced through low temperature, the bleeding amount of the patient in the operation process is further reduced, and the probability of massive bleeding of the patient in the operation process is reduced; therefore, the success rate of surgery is improved.
Owner:THE AFFILIATED HOSPITAL OF QINGDAO UNIV
A kind of fast hemostatic dressing for obstetrics and gynecology and preparation method thereof
InactiveCN105288706BImprove cohesionRapid hemostasisAbsorbent padsBandagesExcessive BleedingEmergency treatment
The invention belongs to the field of medical materials for the department of gynaecology and obstetrics, in particular relates to rapid bleeding-stopping dressing for the department of gynaecology and obstetrics, and further discloses a preparation method of the rapid bleeding-stopping dressing. The rapid bleeding-stopping dressing is prepared by taking carboxymethyl chitosan, sodium carboxymethylcellulose, collagen, radix notoginseng and polyving akohol as raw materials, and the form of firstly foaming and then carrying out freeze drying in the gradient form is adopted in the preparation process; compared with the product obtained by the conventional single freeze drying form in the prior art, the prepared bleeding-stopping dressing has the advantages that on the aspects of absorption and bleeding stopping effects, the technical effect of absorbing blood is greatly promoted; the rapid bleeding-stopping dressing has the optimal bleeding stopping effect for the rapid haemorrhagic disease, can realize stopping bleeding within short time, and can be applicable to the emergency treatment for the acute excessive bleeding of the department of gynaecology and obstetrics.
Owner:李星华
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com